Amneal Pharmaceuticals, Inc. (AMRX)
13.91
+0.82
(+6.26%)
USD |
NASDAQ |
Apr 17, 16:00
13.90
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals EPS Diluted (Quarterly) : 0.1069 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Viatris, Inc. | -0.2951 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 49.57M |
| Revenue (Quarterly) | 814.32M |
| Total Expenses (Quarterly) | 779.24M |
| Enterprise Value | 6.831B |
| Gross Profit Margin (Quarterly) | 36.50% |
| Profit Margin (Quarterly) | 6.09% |
| Earnings Yield | 1.59% |
| Operating Earnings Yield | 8.83% |
| Normalized Earnings Yield | 2.233 |